Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2785070 | Current Opinion in Genetics & Development | 2010 | 9 Pages |
Abstract
Germline sequence mutations in tumour suppressor genes can cause cancer predisposition syndromes. More recently, epimutations have also been proposed to cause at least one such syndrome, hereditary non-polyposis colorectal cancer (HNPCC). ‘Epigenetic predisposition’, is defined as an inherited propensity to an altered epigenetic state in normal tissues that confers a predisposition to disease. Genetic sequence variations acting in cis or trans may contribute to epigenetic variations. Understanding the origin of epimutations will inform cancer risk assessment and will also aid the design and application of new therapies that target the epigenome.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Developmental Biology
Authors
Luke B Hesson, Megan P Hitchins, Robyn L Ward,